Long-term results of blood and marrow transplantation for Hodgkin's Lymphoma

Journal of Clinical Oncology

Volumn 19, Issue 23, 2001, Pages 4314-4321

  Akpek, G ^a   Ambinder, R F ^a   Piantadosi, S ^a   Abrams, R A ^a   Brodsky, R A ^a   Vogelsang, G B ^a   Zahurak, M L ^a   Fuller, D ^a   Miller, C B ^a   Noga, S J ^a   Fuchs, E ^a   Flinn, I W ^a   O'Donnell, P ^a   Seifter, E J ^a   Mann, R B ^a   Jones, R J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE;

ADOLESCENT; ADULT; ARTICLE; AUTOGRAFT; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER RISK; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HODGKIN DISEASE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

EID: 0035575850     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.23.4314     Document Type: Article

References (27)

1. Autologous bone marrow transplantation for patients with relapsed Hodgkin's disease
2. Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease
3. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
4. Allogeneic marrow transplantation for refractory Hodgkin's disease
5. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year Seattle experience
6. Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin's disease
7. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report
8. High-dose, potentially myeloablative chemotherapy and autologous bone marrow transplantation for patients with advanced Hodgkin's disease
9. Intensive therapy with cyclophosphamide, carmustine, etoposide +/- cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy
10. High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: Results in 85 patients with analysis of prognostic factors
11. High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: Analysis of the Stanford University results and prognostic indices
12. Autologous stem-cell transplantation for Hodgkin's disease: Results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group
13. Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the Autologous Blood and Marrow Transplant Registry
14. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
15. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease: European Group for Blood and Bone Marrow Transplantation
16. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease
17. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: A randomized double-blind study in patients undergoing allogeneic marrow transplantation
18. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: Results of a phase I clinical trial
19. Bone marrow graft engineering by counterflow centrifugal elutriation: Results of a phase I-II clinical trial
20. CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment
21. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophos-phamide
22. Nonparametric estimation from incomplete observations
23. Statistical aspects of the analysis of data from retrospective studies of disease
24. Regression models and life tables
25. Myelodysplastic syndrome after autologous bone marrow transplantation: An additional late complication of curative cancer therapy
26. Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
27. Summary slides 2000